-
1.NOVEL ANTIBACTERIAL AGENTS FOR THE TREATMENT OF GRAM POSITIVE INFECTIONS 审中-公开
标题翻译: 用于治疗胃肠道感染的新型抗菌药物公开(公告)号:US20140073558A1
公开(公告)日:2014-03-13
申请号:US13916402
申请日:2013-06-12
IPC分类号: C07K7/54
摘要: The present invention relates to novel lipopeptide compounds, pharmaceutical compositions of these compounds and methods of using these compounds as antibacterial compounds. The compounds of the invention are particularly useful against a variety of bacteria, including resistant strains. The compounds are useful as antibacterial agents against Clostridium difficile.
摘要翻译: 本发明涉及新型脂肽化合物,这些化合物的药物组合物和使用这些化合物作为抗菌化合物的方法。 本发明的化合物特别适用于各种细菌,包括抗性菌株。 这些化合物可用作针对艰难梭菌的抗菌剂。
-
公开(公告)号:US08507647B2
公开(公告)日:2013-08-13
申请号:US12641465
申请日:2009-12-18
IPC分类号: C07K11/02
摘要: The present invention relates to novel lipopeptide compounds, pharmaceutical compositions of these compounds and methods of using these compounds as antibacterial compounds. The compounds of the invention are particularly useful against a variety of bacteria, including resistant strains. The compounds are useful as antibacterial agents against Clostridium difficile.
摘要翻译: 本发明涉及新型脂肽化合物,这些化合物的药物组合物和使用这些化合物作为抗菌化合物的方法。 本发明的化合物特别适用于各种细菌,包括抗性菌株。 这些化合物可用作针对艰难梭菌的抗菌剂。
-
3.Substituted acetylenic imidazo[1,2-A]pyridine compounds as kinase inhibitors 有权
标题翻译: 取代的炔属咪唑并[1,2-A]吡啶化合物作为激酶抑制剂公开(公告)号:US08470851B2
公开(公告)日:2013-06-25
申请号:US13357745
申请日:2012-01-25
申请人: Dong Zou , Wei-Sheng Huang , R. Mathew Thomas , Jan Antoinette C. Romero , Jiwei Qi , Yihan Wang , Xiaotian Zhu , William C. Shakespeare , Rajeswari Sundaramoorthi , Chester A. Metcalf, III , David C. Dalgarno , Tomi K. Sawyer
发明人: Dong Zou , Wei-Sheng Huang , R. Mathew Thomas , Jan Antoinette C. Romero , Jiwei Qi , Yihan Wang , Xiaotian Zhu , William C. Shakespeare , Rajeswari Sundaramoorthi , Chester A. Metcalf, III , David C. Dalgarno , Tomi K. Sawyer
IPC分类号: A61K31/44
CPC分类号: C07D471/04 , C07D473/34 , C07D487/04
摘要: This invention relates to compounds of the general formula: in which the variable groups are as defined herein, and to their preparation and use.
摘要翻译: 本发明涉及以下通式的化合物:其中可变基团如本文所定义,及其制备和用途。
-
公开(公告)号:US07115589B2
公开(公告)日:2006-10-03
申请号:US09740393
申请日:2000-12-18
申请人: Manfred Weigele , Tomi K. Sawyer , Regine Bohacek , William C. Shakespeare , Rajeswari Sundaramoorthi , Yihan Wang , David C. Dalgarno , Chester A. Metcalf, III
发明人: Manfred Weigele , Tomi K. Sawyer , Regine Bohacek , William C. Shakespeare , Rajeswari Sundaramoorthi , Yihan Wang , David C. Dalgarno , Chester A. Metcalf, III
IPC分类号: C07F9/6561 , A61K31/675 , A61P19/10 , A61P19/08 , A61P35/00
CPC分类号: C07D471/04 , A61K47/548 , C07D487/04 , C07F9/4012 , C07F9/405 , C07F9/58 , C07F9/65583 , C07F9/6561 , C07F9/65616
摘要: This invention relates to compounds of the general formula: in which RA, RB, RC and RD are as defined herein, and to their preparation and use. In these compounds, RB is an aliphatic, heteroaliphatic, aryl, or heteroaryl moiety which comprises one or more phosphorus-containing moieties.
摘要翻译: 本发明涉及以下通式的化合物:其中R A,R B,R C和R D D均为 >如本文所定义,以及其制备和使用。 在这些化合物中,R B是包含一个或多个含磷部分的脂族,杂脂族,芳基或杂芳基部分。
-
公开(公告)号:US07009054B2
公开(公告)日:2006-03-07
申请号:US10716239
申请日:2003-11-17
申请人: Yihan Wang , Chester A. Metcalf, III , William C. Shakespeare , Tomi K. Sawyer , Regine Bohacek , Rajeswari Sundaramoorthi
发明人: Yihan Wang , Chester A. Metcalf, III , William C. Shakespeare , Tomi K. Sawyer , Regine Bohacek , Rajeswari Sundaramoorthi
IPC分类号: C07D215/38 , A61K31/66
CPC分类号: C07F9/3821 , C07F9/4012 , C07F9/60 , C07F9/65583
摘要: This invention relates to compounds of the general formula: in which RA, RB, RC and RD are as defined herein, and to their preparation and use.
摘要翻译: 本发明涉及以下通式的化合物:其中R A,R B,R C和R D D均为 >如本文所定义,以及其制备和使用。
-
公开(公告)号:US06960572B2
公开(公告)日:2005-11-01
申请号:US10177472
申请日:2002-06-21
申请人: William C. Shakespeare , Tomi K. Sawyer , Chester A. Metcalf, III , Yihan Wang , Regine Bohacek
发明人: William C. Shakespeare , Tomi K. Sawyer , Chester A. Metcalf, III , Yihan Wang , Regine Bohacek
IPC分类号: C07B61/00 , C07D209/30 , C07D209/34 , C07D209/40 , C07D401/04 , C07D401/06 , C07D403/06 , C07D405/06 , C07D409/06 , C07F9/38 , C07F9/572 , C07F9/58 , C07F9/6509 , C07F9/6558 , A61K31/66
CPC分类号: C07D401/04 , C07B2200/11 , C07D209/30 , C07D209/34 , C07D209/40 , C07D401/06 , C07D403/06 , C07D405/06 , C07D409/06 , C07F9/3821 , C07F9/5728 , C07F9/58 , C07F9/650952 , C07F9/65583 , C40B40/00
摘要: This invention relates to compounds of the general formula: in which RA, RB, RC, RD, RE, p, q and X are as defined herein, and to their preparation and use.
摘要翻译: 本发明涉及下列通式的化合物:其中R A,R B,R C,R D, >,R,E,P,q和X如本文所定义,以及它们的制备和用途。
-
公开(公告)号:US06878697B2
公开(公告)日:2005-04-12
申请号:US10177469
申请日:2002-06-21
申请人: Chester A. Metcalf, III , William C. Shakespeare , Tomi K. Sawyer , Yihan Wang , Regine Bohacek
发明人: Chester A. Metcalf, III , William C. Shakespeare , Tomi K. Sawyer , Yihan Wang , Regine Bohacek
IPC分类号: C07D239/42 , C07D401/04 , C07D403/04 , C07F9/6512 , C07F9/6558 , A61K31/506
CPC分类号: C07D239/42 , C07D401/04 , C07D403/04 , C07F9/6512 , C07F9/65583
摘要: This invention relates to compounds of the general formula: in which RA, RB, RC, RD, w, x, y, and z are as defined herein, and to their preparation and use.
摘要翻译: 本发明涉及以下通式的化合物:其中R A,R B,R C,R D,W,x,y和z如本文所定义,以及它们的制备和 使用。
-
公开(公告)号:US08461167B2
公开(公告)日:2013-06-11
申请号:US12227002
申请日:2007-05-08
申请人: Yihan Wang , Xiaotian Zhu , Rajeswari Sundaramoorthi , Wei-Sheng Huang , Dong Zou , R. Mathew Thomas , Jiwei Qi , Jan Antoinette C. Romero , David C. Dalgarno , William C. Shakespeare , Tomi K. Sawyer , Chester A. Metcalf, III
发明人: Yihan Wang , Xiaotian Zhu , Rajeswari Sundaramoorthi , Wei-Sheng Huang , Dong Zou , R. Mathew Thomas , Jiwei Qi , Jan Antoinette C. Romero , David C. Dalgarno , William C. Shakespeare , Tomi K. Sawyer , Chester A. Metcalf, III
IPC分类号: A01N43/54 , A61K31/505 , C07D239/02
CPC分类号: C07D213/56 , C07D213/73 , C07D213/75 , C07D213/78 , C07D217/14 , C07D217/22 , C07D237/20 , C07D237/28 , C07D239/26 , C07D241/12 , C07D241/20 , C07D401/12 , C07D401/14 , C07D403/12 , C07D405/06 , C07D413/12 , C07D417/12 , C07D471/04
摘要: This invention relates to compounds of the general formula: in which the variable groups are as defined herein, and to their preparation and use.
-
公开(公告)号:US20130005738A1
公开(公告)日:2013-01-03
申请号:US13612067
申请日:2012-09-12
申请人: William C. Shakespeare , Wei-Sheng Huang , David C. Dalgarno , Xiaotian Zhu , R. Mathew Thomas , Yihan Wang , Jiwei Qi , Rajeswari Sundaramoorthi , Dong Zou , Chester A. Metcalf, III , Tomi K. Sawyer , Jan Antoinette C. Romero
发明人: William C. Shakespeare , Wei-Sheng Huang , David C. Dalgarno , Xiaotian Zhu , R. Mathew Thomas , Yihan Wang , Jiwei Qi , Rajeswari Sundaramoorthi , Dong Zou , Chester A. Metcalf, III , Tomi K. Sawyer , Jan Antoinette C. Romero
IPC分类号: C07D403/12 , A61P35/00 , C07D417/12 , A61K31/427 , A61K31/496 , A61K31/4178
CPC分类号: C07D231/12 , C07D233/64 , C07D233/90 , C07D277/40 , C07D403/12 , C07D403/14 , C07D417/12 , C07D417/14
摘要: This invention relates to compounds of the general formula: in which the variable groups are as defined herein, and to their preparation and use.
摘要翻译: 本发明涉及以下通式的化合物:其中可变基团如本文所定义,及其制备和用途。
-
10.Substituted acetylenic imidazo[1,2-B]pyridazine compounds as kinase inhibitors 有权
标题翻译: 取代的炔属咪唑并[1,2-B]哒嗪化合物作为激酶抑制剂公开(公告)号:US08114874B2
公开(公告)日:2012-02-14
申请号:US11644849
申请日:2006-12-22
申请人: Dong Zou , Wei-Sheng Huang , R. Mathew Thomas , Jan Antionette C. Romero , Jiwei Qi , Yihan Wang , Xiaotian Zhu , William C. Shakespeare , Rajeswari Sundaramoorthi , Chester A. Metcalf, III , David C. Dalgarno , Tomi K. Sawyer
发明人: Dong Zou , Wei-Sheng Huang , R. Mathew Thomas , Jan Antionette C. Romero , Jiwei Qi , Yihan Wang , Xiaotian Zhu , William C. Shakespeare , Rajeswari Sundaramoorthi , Chester A. Metcalf, III , David C. Dalgarno , Tomi K. Sawyer
IPC分类号: A61K31/495
CPC分类号: C07D471/04 , C07D473/34 , C07D487/04
摘要: This invention relates to compounds of the general formula: in which the variable groups are as defined herein, and to their preparation and use. In particular, the compounds include embodiments in which Ring T is an imidazo[1,2-b]pyridazine ring system, Rings A and B are each aryl and L1 is —C(O)NR1— or —NR1C(O)—. Uses for the compounds and for compositions containing them include treatment of cancer and other diseases mediated by protein kinases.
摘要翻译: 本发明涉及以下通式的化合物:其中可变基团如本文所定义,及其制备和用途。 特别地,化合物包括其中环T是咪唑并[1,2-b]哒嗪环体系的实施方案,环A和B各自为芳基且L 1为-C(O)NR 1 - 或-NR 1 C(O) - 。 用于化合物和含有它们的组合物的用途包括治疗由蛋白激酶介导的癌症和其它疾病。
-
-
-
-
-
-
-
-
-